Alliance Global Partners lowered shares of Viveve Medical (NASDAQ:VIVE – Get Rating) from a buy rating to a neutral rating in a report issued on Monday morning, The Fly reports.
Viveve Medical Price Performance
Shares of NASDAQ:VIVE opened at $0.10 on Monday. The company's fifty day moving average price is $0.45 and its 200-day moving average price is $0.61. The firm has a market capitalization of $1.04 million, a price-to-earnings ratio of -0.04 and a beta of 0.35. Viveve Medical has a one year low of $0.09 and a one year high of $1.24.
Get
Viveve Medical alerts:
Viveve Medical (NASDAQ:VIVE – Get Rating) last issued its quarterly earnings results on Thursday, November 10th. The company reported ($0.59) EPS for the quarter. The company had revenue of $1.68 million during the quarter. Viveve Medical had a negative return on equity of 306.23% and a negative net margin of 355.33%.
Viveve Medical Company Profile
(Get Rating)
Viveve Medical, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components.
Featured Articles
- Get a free copy of the StockNews.com research report on Viveve Medical (VIVE)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft's Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Alliance Global Partners股价下跌万岁医疗(纳斯达克:VIVE-GET评级)在周一上午发布的一份报告中,Fly的评级从买入评级变成了中性评级。
Viveve医疗性价比
纳斯达克:VIVE的股价周一开盘报0.1美元。该公司的50日移动均线价格为0.45美元,200日移动均线价格为0.61美元。该公司市值为104万美元,市盈率为-0.04,贝塔系数为0.35。Viveve Medical的一年低点为0.09美元,一年高位为1.24美元。
到达
Viveve医疗警报:
Viveve Medical(纳斯达克:VIVE-GET评级)最近一次发布季度收益报告是在11月10日(星期四)。该公司公布了该季度每股收益(0.59美元)。该公司本季度的收入为168万美元。Viveve Medical的净资产回报率为负306.23%,净利润率为负355.33%。
Viveve医疗公司简介
(获取评级)
Viveve Medical,Inc.与其子公司一起设计、开发、制造和销售用于非侵入性治疗阴道内分泌松弛、性功能、阴道年轻化和压力性尿失禁的医疗设备。该公司提供的Viveve系统包括射频发生器、可重复使用的手机和治疗尖端,以及冷冻剂罐和其他消耗品部件。
专题文章
- 免费获取StockNews.com关于Viveve Medical的研究报告(VIVE)
- 诺斯罗普·格鲁曼公司的抛售是一个机会吗?
- Under Armor Stock的新任CEO是最糟糕的吗?
- 微软投资ChatGBT对微软股票意味着什么?
- 分析师喜欢斯凯奇美国公司的Fit
- 我们能相信标普500指数的涨势吗
接受Viveve医学日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Viveve Medical和相关公司的最新新闻和分析师评级的每日简要摘要。